{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:20:39Z","timestamp":1787883639872,"version":"build-2784847793"},"reference-count":67,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Inflammation and coagulation are intricately linked. Although some studies have documented proinflammatory drivers of coagulation, the role of anti-inflammatory cytokines and the underlying mechanisms in the modulation of coagulation, platelet function, and thrombosis remains poorly characterized. In this study, we demonstrate that interleukin-4 (IL-4), an anti-inflammatory cytokine, plays a crucial role in regulating platelet function and thrombus formation. IL-4 inhibited collagen-induced calcium mobilization, P-selectin expression, ATP release, integrin \u03b1IIb\u03b23 activation, platelet spreading, and platelet aggregation. IL-4 binds to residues 38 to 46 within glycoprotein VI (GPVI)\u2019s extracellular collagen-binding domain and suppresses downstream signaling by inhibiting phosphorylation of phospholipase C\u03b32 and protein kinase C. A GPVI-derived interfering peptide (RR9) binding to IL-4 disrupted the IL-4\u2013GPVI complex and reversed the inhibitory effects of IL-4 on platelets. In vivo, IL-4 overexpression or IV administration inhibited platelet intracellular calcium mobilization, ATP release, and aggregation; prolonged bleeding time; and attenuated both arterial and venous thrombosis. Conversely, IL-4 knockout, anti\u2013IL-4 antibody treatment, or RR9 treatment enhanced platelet reactivity, promoted hemostasis, and aggravated thrombosis. Our findings reveal that IL-4 negatively regulates platelet function through direct interaction with GPVI, thereby facilitating cross talk among inflammation, hemostasis, and thrombosis. Therefore, modulating IL-4 levels may provide a novel strategy for the treatment of thrombotic disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031889","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:21:31Z","timestamp":1777915291000},"page":"1205-1217","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Inhibiting thromboinflammation via interleukin-4 binding to platelet glycoprotein VI and suppression of thrombosis"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7400-6505","authenticated-orcid":false,"given":"Shiping","family":"Lin","sequence":"first","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9892-2985","authenticated-orcid":false,"given":"Yuanjie","family":"Yin","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-8986","authenticated-orcid":false,"given":"Shaoying","family":"Wang","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-2013","authenticated-orcid":false,"given":"Chuanfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"2Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1871-0928","authenticated-orcid":false,"given":"Musan","family":"Yan","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1711-3883","authenticated-orcid":false,"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2425-7935","authenticated-orcid":false,"given":"Xin","family":"Jin","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9836-5088","authenticated-orcid":false,"given":"Qikai","family":"Yin","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xue","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-6160","authenticated-orcid":false,"given":"Xiaopeng","family":"Tang","sequence":"additional","affiliation":[{"name":"1School of Basic Medicine, Qingdao University, Qingdao, China"},{"name":"3Shandong Key Laboratory of Pathogenesis and Prevention of Brain Diseases, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9","key":"2026082711215941600_bib1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"issue":"2 suppl","key":"2026082711215941600_bib2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit Care Med"},{"issue":"6","key":"2026082711215941600_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2016-05-718114","article-title":"The role of leukocytes in thrombosis","volume":"128","author":"Swystun","year":"2016","journal-title":"Blood"},{"issue":"22","key":"2026082711215941600_bib4","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"issue":"9516","key":"2026082711215941600_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(06)68474-2","article-title":"Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting","volume":"367","author":"Smeeth","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"2026082711215941600_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"2026082711215941600_bib7","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/01.CCM.0000281468.94108.4B","article-title":"Disseminated intravascular coagulation","volume":"35","author":"Levi","year":"2007","journal-title":"Crit Care Med"},{"issue":"6","key":"2026082711215941600_bib8","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"15","key":"2026082711215941600_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/eurjpc\/zwad124","article-title":"Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population","volume":"30","author":"Sleutjes","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"2026082711215941600_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1538-7836.2003.00261.x","article-title":"Inflammation and thrombosis","volume":"1","author":"Esmon","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026082711215941600_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhep.2014.08.050","article-title":"C5aR, TNF-\u03b1, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis","volume":"62","author":"Liu","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"2026082711215941600_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/ten.teb.2018.0157","article-title":"The bidirectional interactions between inflammation and coagulation in fracture hematoma","volume":"25","author":"Ma","year":"2019","journal-title":"Tissue Eng Part B Rev"},{"issue":"8","key":"2026082711215941600_bib13","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ Res"},{"issue":"3","key":"2026082711215941600_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.ATV.0000114567.76772.33","article-title":"Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis","volume":"24","author":"Grainger","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2026082711215941600_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jth.14759","article-title":"Cytokine and chemokine regulation of venous thromboembolism","volume":"18","author":"Najem","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026082711215941600_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2141.1996.d01-1893.x","article-title":"Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines","volume":"95","author":"Ernofsson","year":"1996","journal-title":"Br J Haematol"},{"issue":"8","key":"2026082711215941600_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","article-title":"The role of platelets in immune-mediated inflammatory diseases","volume":"23","author":"Scherlinger","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2026082711215941600_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"2026082711215941600_bib19","doi-asserted-by":"crossref","first-page":"101155","DOI":"10.1016\/j.blre.2023.101155","article-title":"Platelet factor 4(PF4) and its multiple roles in diseases","volume":"64","author":"Liu","year":"2024","journal-title":"Blood Rev"},{"issue":"4","key":"2026082711215941600_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.11.023","article-title":"Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis","volume":"125","author":"Kowalska","year":"2010","journal-title":"Thromb Res"},{"issue":"3","key":"2026082711215941600_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2004-831051","article-title":"Platelet factor 4: an inhibitor of angiogenesis","volume":"30","author":"Bikfalvi","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2026082711215941600_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2021","journal-title":"haematol"},{"issue":"1","key":"2026082711215941600_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood.2023020872","article-title":"PF4 activates the c-Mpl\u2013Jak2 pathway in platelets","volume":"143","author":"Buka","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2026082711215941600_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0039-1688744","article-title":"Report of the working party on platelets. Platelet factor 4 (PF4), platelet protein with heparin neutralizing activity","volume":"36","author":"Niewiarowski","year":"1976","journal-title":"Thromb Haemost"},{"issue":"4","key":"2026082711215941600_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0049-3848(80)90284-4","article-title":"Inhibition of contact activation by platelet factor 4","volume":"20","author":"Scully","year":"1980","journal-title":"Thromb Res"},{"issue":"1","key":"2026082711215941600_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood-2002-11-3529","article-title":"Platelet factor 4 enhances generation of activated protein C in vitro and in vivo","volume":"102","author":"Slungaard","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2026082711215941600_bib27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaci.2005.09.035","article-title":"CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production","volume":"116","author":"Romagnani","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"2026082711215941600_bib28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1096\/fj.03-1435fje","article-title":"Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells","volume":"18","author":"Fricke","year":"2004","journal-title":"Faseb j"},{"issue":"9","key":"2026082711215941600_bib29","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V77.9.1859.1859","article-title":"Interleukin-4: a prototypic immunoregulatory lymphokine","volume":"77","author":"Paul","year":"1991","journal-title":"Blood"},{"issue":"3","key":"2026082711215941600_bib30","first-page":"344","article-title":"IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages","volume":"72","author":"Hart","year":"1991","journal-title":"Immunology"},{"issue":"7","key":"2026082711215941600_bib31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood.V76.7.1392.1392","article-title":"Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes","volume":"76","author":"te Velde","year":"1990","journal-title":"Blood"},{"issue":"5032","key":"2026082711215941600_bib32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.1948049","article-title":"Generation and analysis of interleukin-4 deficient mice","volume":"254","author":"K\u00fchn","year":"1991","journal-title":"Science"},{"issue":"4","key":"2026082711215941600_bib33","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood.V74.4.1222.1222","article-title":"Interleukin-4 stimulates human monocytes to produce tissue-type plasminogen activator","volume":"74","author":"Hart","year":"1989","journal-title":"Blood"},{"issue":"2","key":"2026082711215941600_bib34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V78.2.410.410","article-title":"Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells","volume":"78","author":"Kapiotis","year":"1991","journal-title":"Blood"},{"issue":"3","key":"2026082711215941600_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V81.3.624.624","article-title":"Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture","volume":"81","author":"Sonoda","year":"1993","journal-title":"Blood"},{"issue":"1","key":"2026082711215941600_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-5793(92)81139-D","article-title":"IL-4 inhibits LPS-IL-1\u03b2- and TNF\u03b1-induced expression of tissue factor in endothelial cells and monocytes","volume":"310","author":"Herbert","year":"1992","journal-title":"FEBS Lett"},{"issue":"9","key":"2026082711215941600_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood.2024026476","article-title":"Deficiency of neutrophil gelatinase-associated lipocalin elicits a hemophilia-like bleeding and clotting disorder in mice","volume":"145","author":"Xue","year":"2025","journal-title":"Blood"},{"issue":"19","key":"2026082711215941600_bib38","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1182\/blood.2022016410","article-title":"Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2026082711215941600_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCRESAHA.119.316453","article-title":"Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability","volume":"127","author":"Tang","year":"2020","journal-title":"Circ Res"},{"issue":"2","key":"2026082711215941600_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41422-019-0260-6","article-title":"Transferrin plays a central role in coagulation balance by interacting with clotting factors","volume":"30","author":"Tang","year":"2020","journal-title":"Cell Res"},{"issue":"8","key":"2026082711215941600_bib41","doi-asserted-by":"crossref","first-page":"102260","DOI":"10.1016\/j.xcrm.2025.102260","article-title":"High-fat diet increases circulating palmitic acid produced by gut Bacteroides thetaiotaomicron to promote thrombosis","volume":"6","author":"Huang","year":"2025","journal-title":"Cell Rep Med"},{"issue":"14","key":"2026082711215941600_bib42","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.2025030270","article-title":"Estrogen upregulates lactoferrin to induce hypercoagulability for hemostatic protection during pregnancy","volume":"147","author":"Cheng","year":"2026","journal-title":"Blood"},{"issue":"6","key":"2026082711215941600_bib43","first-page":"83","article-title":"The inflammatory role of platelets via their TLRs and siglec receptors","volume":"6","author":"Cognasse","year":"2015","journal-title":"Front Immunol"},{"issue":"3","key":"2026082711215941600_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0014-5793(93)80941-M","article-title":"IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes","volume":"328","author":"Herbert","year":"1993","journal-title":"FEBS Lett"},{"issue":"1","key":"2026082711215941600_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2015.01.038","article-title":"History of interleukin-4","volume":"75","author":"Paul","year":"2015","journal-title":"Cytokine"},{"issue":"4","key":"2026082711215941600_bib46","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"issue":"1","key":"2026082711215941600_bib47","doi-asserted-by":"crossref","first-page":"065237","DOI":"10.1155\/MI\/2006\/65237","article-title":"Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique andof probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors","volume":"2006","author":"Martin","year":"2006","journal-title":"Mediators Inflamm"},{"issue":"12","key":"2026082711215941600_bib48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1017\/S0031182011001181","article-title":"Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria","volume":"138","author":"Imai","year":"2011","journal-title":"Parasitology"},{"issue":"1","key":"2026082711215941600_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J Exp Med"},{"issue":"1","key":"2026082711215941600_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/jmcc.2000.1278","article-title":"IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells","volume":"33","author":"Lee","year":"2001","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"2026082711215941600_bib51","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1084\/jem.20050324","article-title":"Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells","volume":"201","author":"Yao","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"2026082711215941600_bib52","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2026082711215941600_bib53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2003-03-0717","article-title":"The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion","volume":"102","author":"Kato","year":"2003","journal-title":"Blood"},{"issue":"17","key":"2026082711215941600_bib54","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","article-title":"Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding","volume":"115","author":"Kleinschnitz","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"2026082711215941600_bib55","doi-asserted-by":"crossref","first-page":"104473","DOI":"10.1016\/j.drudis.2025.104473","article-title":"Blocking platelet glycoprotein VI (GPVI) as a promising antithrombotic treatment","volume":"30","author":"Li","year":"2025","journal-title":"Drug Discov Today"},{"issue":"1","key":"2026082711215941600_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.spinee.2019.06.025","article-title":"Anti-inflammatory effects of interleukin-4 on intervertebral disc cells","volume":"20","author":"Kedong","year":"2020","journal-title":"Spine J"},{"issue":"3","key":"2026082711215941600_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/bj2180725","article-title":"Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4","volume":"218","author":"Lane","year":"1984","journal-title":"Biochem J"},{"issue":"50","key":"2026082711215941600_bib58","doi-asserted-by":"crossref","first-page":"31785","DOI":"10.1074\/jbc.272.50.31785","article-title":"Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C","volume":"272","author":"Dudek","year":"1997","journal-title":"J Biol Chem"},{"issue":"12","key":"2026082711215941600_bib59","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/CIRCRESAHA.121.318225","article-title":"Inflammation, infection and venous thromboembolism","volume":"128","author":"Colling","year":"2021","journal-title":"Circ Res"},{"issue":"6","key":"2026082711215941600_bib60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jacc.2021.06.010","article-title":"Factor XI inhibition to uncouple thrombosis from hemostasis: JACC review topic of the week","volume":"78","author":"Hsu","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1 suppl","key":"2026082711215941600_bib61","doi-asserted-by":"crossref","first-page":"108S","DOI":"10.1378\/chest.119.1_suppl.108S","article-title":"Hemorrhagic complications of anticoagulant treatment","volume":"119","author":"Levine","year":"2001","journal-title":"CHEST"},{"issue":"8","key":"2026082711215941600_bib62","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jamainternmed.2016.3057","article-title":"Risk of bleeding and thrombosis in patients 70 years or older using vitamin K antagonists","volume":"176","author":"Kooistra","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"25","key":"2026082711215941600_bib63","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"2026082711215941600_bib64","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2026082711215941600_bib65","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1055\/s-0039-1695770","article-title":"From patients to platelets and back again: pharmacological approaches to glycoprotein VI, a thrilling antithrombotic target with minor bleeding risks","volume":"119","author":"Martins Lima","year":"2019","journal-title":"Thromb Haemost"},{"issue":"7","key":"2026082711215941600_bib66","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1538-7836.2010.03875.x","article-title":"GPVI and CLEC-2 in hemostasis and vascular integrity","volume":"8","author":"Watson","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2026082711215941600_bib67","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood-2009-03-213504","article-title":"Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations","volume":"114","author":"Dumont","year":"2009","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/9\/1205\/2541579\/blood_bld-2025-031889-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/9\/1205\/2541579\/blood_bld-2025-031889-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:22:08Z","timestamp":1787844128000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/9\/1205\/568168\/Inhibiting-thromboinflammation-via-interleukin-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031889","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,27]]},"published":{"date-parts":[[2026,8,27]]}}}